Posted by Michael Wonder on 12 Aug 2021
MHRA nod for Janssen’s relapsing multiple sclerosis drug Ponvory
12 August 2021 - The UK’s Medicines and Healthcare Products Regulatory Agency has approved Ponvory (ponesimod) for the treatment relapsing multiple sclerosis.
The British medicines regulator has cleared Ponvory for the treatment of adult patients with relapsing multiple sclerosis with active disease, as defined by clinical or imaging features.
